)
AOTI (AOTI) investor relations material
AOTI H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved 21% year-on-year revenue growth in H1 2025 to $31.8m, led by Medicaid and VA segments, despite significant U.S. market headwinds and regulatory disruptions.
Maintained market leadership in topical oxygen therapy for chronic wounds, with strong clinical validation and international endorsements.
Operational adjustments and cost containment measures implemented to address U.S. efficiency initiatives and the "Big Beautiful Bill" Act, particularly affecting Q2.
Secured key validation milestones: California Medicaid Provider ID, Germany G-BA recommendation, and UK NICE guideline inclusion for TWO2Ⓡ therapy.
Strategic focus on value-based care and durable wound healing, targeting high-cost areas like diabetic foot ulcers.
Financial highlights
Revenues increased by 20.9% to $31.8m in H1 2025, with Q1 growth at 26% and Q2 slowing to 16% due to U.S. efficiency measures.
Adjusted EBITDA declined 9.5% to $3.1m (margin 9.6%), reflecting higher operating expenses and investments for growth.
Net profit of $0.2m in H1 2025, a turnaround from a $3.9m loss in H1 2024.
Gross margin improved to 87.7% (up from 87.3%).
Operating cash outflow was negative $4.7m, mainly due to delayed payments from Arizona Medicaid.
Outlook and guidance
On track to deliver revised FY 2025 guidance: revenue growth in the mid-teens and low double-digit adjusted EBITDA margin.
Trading in July and August consistent with guidance; growth trajectory expected to improve as headwinds subside.
Expecting gradual revenue contributions from California, Germany, and the U.K. as new approvals and frameworks take effect.
- TimeTickerHeadlineOpen
- DNLM
Sales and profit rose, market share reached 7.7%, and margins improved despite a tough market. - 386
Profit fell 16% to RMB48.9B, but cost cuts and a 75% payout ratio were maintained. - 386
Net profit and revenue fell on lower oil prices and weak margins, despite improved cash flow. - DNLM
Sales and digital growth, margin expansion, and strategic investments drive strong FY25 results. - DNLM
Sales up 3.8% to £1,771m, profit before tax £211m, digital sales 40%, market share 7.9%. - 9412
Profits and equity improved, with upward revisions to full-year forecasts and new subsidiaries added. - NVDA
AI is transforming enterprises by enabling intent-driven innovation and technology-first strategies. - DNLM
H1 sales up 3.6% to £926m; digital mix 41%; PBT to hit lower end of consensus. - CRW
Double-digit growth, strong cash flow, and new leadership drive confidence for FY25. - 7011
Strong revenue and profit growth in FY2025, with raised guidance and key divestiture impact.
Next AOTI earnings date
Next AOTI earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)